Guideline for gynecomastia;Leitlinie - Gynäkomastie

JDDG - Journal of the German Society of Dermatology

Volumn 3, Issue 7, 2005, Pages 561-565

  Schreiber, Gerhard ^a   Schanz, Stefan ^b   Köhn, Frank Michael ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANDROSTANOLONE; CLOMIFENE CITRATE; DANAZOL; TAMOXIFEN; TESTOLACTONE;

CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; GYNECOMASTIA; HUMAN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; SHORT SURVEY;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS, MALE; DIAGNOSIS, DIFFERENTIAL; GYNECOMASTIA; HUMANS; INFANT, NEWBORN; MALE; PRACTICE GUIDELINES;

EID: 21744437493     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2005.05502.x     Document Type: Short Survey

References (32)

1. Alagaratnam TT. Idiopathic gynecomastia treated with tamoxifen: a preliminary report. Clin. Ther. 1987; 9: 483-487.
2. Backe J. Brustkrebs des Mannes. Dt. Ärzteblatt 2002; 99: B970-B974.
3. Beck W, Stubbe P. Endocrinological studies of the hypothalamo-pituitary gonadal axis during danazol treatment in puberral boys with marked gynecomastias. Horm. Metab. Res. 1982; 14: 653-657.
4. Bork K. Haut und Brust. Dermatologische Aspekte der Brustkrankheiten. Fischer-Verlag 1995; Stuttgart, Jena, New York.
5. Braunstein GD, Classman HA. Gynecomastia. Curr. Ther. Endocrinol. Metab. 1997; 6: 401-404.
6. Buckle R. Danazol therapy in gynaecomastia; recent experience and indications for therapy. Postgrad. Med. J. 1979; 55 Suppl 5: 71-78.
7. Bullmann C, Jockenhövel F. Gynäkomastie beim Mann. Fortschr. Med. 1998; 116: 18-22.
8. Daniels IR, Layer GT. Gynaecomastia. Eur. J. Surg. 2001; 167: 885-892.
9. Daniels IR, Layer GT. How should gynaecomastia be managed? ANZ. J. Surg. 2003; 73: 213-216.
10. Eberle AJ, Sparrow JT, Keenan BS. Treatment of persistent pubertal gynecomastia with dihydrotestosterone heptanoate. J. Pediatr. 1986; 109: 144-149.
11. Eversmann T, Moito J, von Werder K. Testosteron- und Ostradiolspiegel bei der Gynakomastie des Mannes. Klini-sche und endokrine Befunde bei Behandlung mit Tamoxifen. Dtsch. Med. Wochenschr. 1984; 109: 1678-1682.
12. Fruhstorfer BH, Malata CM. A systematic approach to the surgical treatment of gynaecomastia. Br. J. Plast. Surg. 2003; 56: 237-246.
13. Jones DJ, Holt SD, Surtees P, Davison DJ, Coptcoat MJ. A comparison of danazol and placebo in the treatment of adult idiopathic gynaecomastia: results of a prospective study in 55 patients. Ann. R. Coll. Surg. Engl. 1990; 72: 296-298.
14. Kauf E. Gynäkomastie im Kindesalter. Fortschr. Med. 1998; 116: 23-26.
15. Khan HN, Rampaul R, Blamey RW. Management of physiological gynaecomastia with tamoxifen. Breast 2004; 13: 61-65.
16. König R, Schönberger W, Neumann P, Benes P, Grimm W. Behandlung der ausgeprägten Pubertätsgynäkomastie mit Tamoxifen. Klin. Padiatr. 1987; 199: 389-391.
17. Kühl C, Schild H. MR-Mammografie. Dt. Ärztebl. 1999; 96: 1897-1904.
18. Kühn JM, Roca R, Laudat MH, Rieu M, Luton JP, Bricaire H. Studies on the treatment of idiopathic gynaecomastia with percutaneous dihydrotestosterone. Clin. Endocrinol. 1983; 19: 513-520.
19. Lazala C, Sänger P. Pubertal gynecomastia. J. Pediatr. Endocrinol. Metab. 2002; 15: 553-560.
20. LeRoith D, Sobel R, Glick SM. The effect of clomiphene citrate on pubertal gynaecomastia. Acta Endocrinol. (Copenh.) 1980; 95: 177-180.
21. McDermott MT, Hofeldt FD, Kidd GS. Tamoxifen therapy for painful idiopathic gynecomastia. South. Med. J. 1990; 83: 1283-1285.
22. Mathur R, Braunstein GD. Gynecomastia: pathomechanisms and treatment strategies. Horm. Res. 1997; 48: 95-102.
23. Parker LN, Gray DR, Lai MK, Levin ER. Treatment of gynecomastia with tamoxifen: a double-blind crossover study. Metabolism 1986; 35: 705-708.
24. Plourde PV, Kulin HE, Santner SJ. Clomiphene in the treatment of adolescent gynecomastia. Clinical and endocrine studies. Am. J. Dis. Child. 1983; 137: 1080-1082.
25. Rhoden EL, Morgentaler A. Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole. Int. J. Impot. Res. 2004; 16: 95-97.
26. Schreiber G. Das männliche Mammacarcinom. In: Andrologie. Krankheiten der männlichen Geschlechtsorgane. Hrsg. Krause W und Weidner W. Enke Stuttgart 1998, S. 303-305.
27. Schreiber G. Diagnostik der Gynäkomastie. Dtsch. Med. Wochenschr. 1999; 124: 1438-1439.
28. Schürmeyer TH, Füchsel K, Nittritz N. Seltene Ursache einer Gynäkomastie eines 70jährigen Mannes. Fortschr. Med. 1997; 115: 40-43.
29. Seibel V, Müller H-H, Krause W. Die Inzidenz der Gynäkomastie bei dermatologischen Patienten. Hautarzt 1998; 49: 382-387.
30. Stepanas AV, Burnet RB, Harding PE, Wise PH. Clomiphene in the treatment of pubertal-adolescent gynecomastia: a preliminary report. J. Pediatr. 1977; 90: 651-653.
31. Ting AC, Chow LW, Leung YF. Comparison of tamoxifen with danazol in the management of idiopathic gynecomastia. Am. Surg. 2000; 66: 38-40.
32. Zachmann M, Eiholzer U, Muritano M, Werder EA, Manella B. Treatment of pubertal gynecomastia with testolactone. Acta. Endocrinol. Suppl. (Copenh.) 1986; 279: 218-226.